Nebula Research & Development LLC Recursion Pharmaceuticals, Inc. Transaction History
Nebula Research & Development LLC
- $1.08 Trillion
- Q1 2025
A detailed history of Nebula Research & Development LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 101,623 shares of RXRX stock, worth $444,092. This represents 0.05% of its overall portfolio holdings.
Number of Shares
101,623
Previous 37,046
174.32%
Holding current value
$444,092
Previous $250 Million
114.66%
% of portfolio
0.05%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding RXRX
# of Institutions
365Shares Held
286MCall Options Held
3.28MPut Options Held
3.16M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl34.8MShares$152 Million1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA32.3MShares$141 Million0.0% of portfolio
-
Baillie Gifford & CO24.4MShares$107 Million0.12% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$75.6 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$64.1 Million0.27% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $789M
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...